Earnings Feed
Sign Up
Home/Filings/4/0001209191-22-002590
4//SEC Filing

GIVEN DOUGLAS B 4

Accession 0001209191-22-002590

CIK 0000879407other
View on SEC.govCompany Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 8:10 PM ET

Size

6.9 KB

Accession

0001209191-22-002590

Insider Transaction Report

Form 4
Period: 2022-01-07
ARROWHEAD PHARMACEUTICALS, INC.ARWR
GIVEN DOUGLAS B
Director
Transactions
  • Award

    Common Stock

    2022-01-07+6,400→ 116,268 total
Holdings

  • Common Stock

    (indirect: By Trust)
    13,875

  • Common Stock

    (indirect: By Trust)
    12,500
Footnotes (3)
  • [F1]Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
  • [F2]Represents securities owned directly by Anne Given Trust ("AG Trust"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.
  • [F3]Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.

Documents

1 file

Issuer

ARROWHEAD PHARMACEUTICALS, INC.

CIK 0000879407

→
Entity typeother

Related Parties

1
  • filerCIK 0001156207

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 8:10 PM ET
Size
6.9 KB
View on SEC.gov